search icon

    Market Snapshot

    • S&P Futures

      4,276.75

    • Dow Futures

      33,884

    • Nasdaq Futures

      13,514.5

    blog search icon

    CEL-SCI Corporation

    (AMEX:CVM)

    $4.32

    -$0.19

    -4.21%

    CEL-SCI Corporation Chart

    CVM Stock Price Today

    CEL-SCI Corporation (CVM) stock declined over -4.21% intraday to trade at $4.32 a share on AMEX. The stock opened with a loss of -7.10% at $4.7 and touched an intraday high of $5.016, falling -6.49% against the last close of $4.62. The stock went to a low of $4.44 during the session.

    Stock Snapshot

    $4.62

    Prev. Close

    187.44 Million

    Market Cap

    $4.44

    Day Low

    $4.7

    Open

    43.24 Million

    Number of Shares

    $5.016

    Day High

    -

    P/E ratio

    -0.85

    EPS (TTM)

    0.79

    Cash Flow per Share

    15.57

    Free Float in %

    1.31

    Book Value

    417,493

    Volume

    CEL-SCI Corporation Historical Data

    DateOpenHighLowCloseVolume
    2022-08-17$4.7$5.016$4.44$4.51347,873
    2022-08-16$4.65$5$4.61$4.62487,100
    2022-08-15$4.2$5.42$4.06$5.231,078,200
    2022-08-12$4.05$4.2$4.02$4.17113,500
    2022-08-11$4.04$4.57$3.85$4565,600
    2022-08-10$3.97$3.98$3.83$3.89173,200
    2022-08-09$4.08$4.26$3.88$3.89217,700
    2022-08-08$4.2$4.28$3.98$4.13240,300
    2022-08-05$3.93$4.3$3.93$4.21432,400
    2022-08-04$3.85$4$3.71$4256,300

    Contact Details

    8229 Boone Boulevard
    Suite 802
    Vienna, VA 22182
    United States

    Webiste:CVM

    703 506 9460

    Company Information

    Employees-

    Beta1.7

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-09-29

    SectorHealth Care

    IndustryBiotechnology

    About Company

    CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

    Frequently Asked Questions

    icon

    What is the current CEL-SCI Corporation (CVM) stock price?

    CEL-SCI Corporation (AMEX: CVM) stock price is $4.32 as of the last check on Wednesday, August 17. During the trading session, CVM stock reached the peak price of $5.016 while $4.44 was the lowest point it dropped to.

    icon

    CVM's industry and sector of operation?

    The AMEX listed CVM is part of Biotechnology industry that operates in the broader Health Care sector. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer.

    icon

    Who are the executives of CVM?

    Mr. Geert R. Kersten
    CEO, Principal Accounting & Financial Officer, Treasurer and Director
    Mr. Geert R. Kersten Esq.
    Chief Exec. & Financial Officer, Treasurer and Director
    Ms. Patricia B. Prichep
    Sr. VP of Operations & Corp. Sec.
    Dr. Eyal Talor Ph.D.
    Chief Scientific Officer

    icon

    What is the CVM stock price today?

    CVM stock traded closed the last session at $4.51, which is -$0.1899999999999995 or -4.212860310421275% lower than its previous close of $4.62. CVM's current trading price is 81.12% lower than its 52-week high of $12.9 where as its distance from 52-week low of 2.49% is -65.04%.

    icon

    How many employees does CVM have?

    Number of CVM employees currently stands at -. CVM operates from 8229 Boone Boulevard, Suite 802, Vienna, VA 22182, United States.

    icon

    Link for CVM official website?

    Official Webiste of $CVM is: https://cel-sci.com

    icon

    How do I contact CVM?

    CVM could be contacted at CVM operates from 8229 Boone Boulevard, Suite 802, Vienna, VA 22182, United States, or at phone #703 506 9460 and can also be accessed through its website.

    icon

    How many shares of CVM are traded daily?

    CVM stock volume for the day was 417,493 shares while in the previous session number of CVM shares traded was 347,873 . The average number of CVM shares traded daily for last 3 months was 636.58 Thousands.

    icon

    How much did CVM change today?

    The percentage change in CVM stock occurred in the recent session was -4.212860310421275% while the dollar amount for the price change in CVM stock was -$0.1899999999999995.

    icon

    What price range CVM stock been trading in?

    In the recent session, the day high for CVM stock was $5.016 while the low for CVM stock touched on the day was $4.44.

    icon

    What is the market cap of CVM currently?

    The market value of CVM currently stands at 187.44 Million with its latest stock price at $4.32 and 43.24 Million of its shares outstanding.